Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...

Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...

Despite falling short of its primary Phase II objective, Nektar plans to push its T cell stimulator rezpeg into Phase III ...

A growing body of research has examined the IRA’s implications for pharmaceutical innovation. Much of this literature has focused on the potential impact on the number of new drug launches, 5, 6 but ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

Rather than thinking that adolescence ends at 18, groundbreaking brain research has shown that critical brain developmental ...

Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and ...

Insmed said on Wednesday it had discontinued the development of its experimental anti-inflammatory drug to treat a chronic sinus condition after it failed to show benefit in a mid-stage study, sending ...